These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15060446)

  • 41. Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia.
    Lu CL; Lin YH; Wong WW; Lin HH; Ho MW; Wang NC; Hsieh SM; Sheng WH; Hung CC; Chen MY
    J Microbiol Immunol Infect; 2011 Aug; 44(4):258-64. PubMed ID: 21524961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Efficacy of atazanavir in simplification regimens].
    Zamora L; Gatell JM
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():14-21. PubMed ID: 20116612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Report from the 2008 joint ICAAC/IDSA meeting. Darunavir and atazanavir: 96-week data from ARTEMIS and CASTLE.
    Sax PE
    AIDS Clin Care; 2008 Dec; 20(12):98. PubMed ID: 19271333
    [No Abstract]   [Full Text] [Related]  

  • 44. Raltegravir and unboosted atazanavir dual therapy in virologically suppressed antiretroviral treatment-experienced HIV patients.
    Cordery DV; Hesse K; Amin J; Cooper DA
    Antivir Ther; 2010; 15(7):1035-8. PubMed ID: 21041919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Knee avascular necrosis in HIV patient.
    Declet VR; Salas AS
    Bol Asoc Med P R; 2015; 107(2):24-6. PubMed ID: 26434077
    [No Abstract]   [Full Text] [Related]  

  • 46. [Safety of atazanavir in patients with HIV and hepatitis B and/or C virus coinfection].
    Rivero A; Camacho A; Pérez-Camacho I; Torre-Cisneros J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():45-8. PubMed ID: 20116617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of six different ritonavir-boosted protease inhibitor-based regimens in heavily antiretroviral-experienced HIV-infected patients.
    de Mendoza C; Valer L; Ribera E; Barreiro P; Martín-Carbonero L; Ramirez G; Soriano V
    HIV Clin Trials; 2006; 7(4):163-71. PubMed ID: 17065028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atazanavir: the advent of a new generation of more convenient protease inhibitors.
    Barreiro P; Rendón A; Rodríguez-Nóvoa S; Soriano V
    HIV Clin Trials; 2005; 6(1):50-61. PubMed ID: 15765311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Occurrence of selective ritonavir nonadherence and dose-staggering in recipients of boosted HIV-1 protease inhibitor therapy.
    Shuter J; Sarlo JA; Rode RA; Zingman BS
    HIV Clin Trials; 2009; 10(3):135-42. PubMed ID: 19632952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
    Landman R; Capitant C; Descamps D; Chazallon C; Peytavin G; Katlama C; Pialoux G; Bentata M; Brun-Vézinet F; Aboulker JP; Yéni P;
    J Antimicrob Chemother; 2009 Jul; 64(1):118-25. PubMed ID: 19420019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial.
    Haas DW; Zala C; Schrader S; Piliero P; Jaeger H; Nunes D; Thiry A; Schnittman S; Sension M;
    AIDS; 2003 Jun; 17(9):1339-49. PubMed ID: 12799555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virological failure and subsequent resistance profiles in individuals exposed to atazanavir.
    Stebbing J; Nathan B; Jones R; McKenna A; Powles T; Bower M; Holmes P; Gazzard B; Nelson M
    AIDS; 2007 Aug; 21(13):1826-8. PubMed ID: 17690587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions.
    Rubio R; Serrano O; Carmena J; Asensi V; Echevarría S; Flores J; Ribera E; Zarraga M; Ocampo A; de la Fuente B; Sepúlveda MA; Mariño AI; Minguez C; Vicent R; Cartón JA; Moyano B; Esteban H; Mahillo B; Serrano L; González-García J;
    HIV Med; 2010 Oct; 11(9):545-53. PubMed ID: 20345884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir.
    Gianotti N; Guffanti M; Galli L; Margonato A; Chiaravalli G; Bigoloni A; Lazzarin A; Castagna A
    AIDS; 2007 Jul; 21(12):1648-51. PubMed ID: 17630564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Efficacy of atazanavir in treatment-naive patients].
    Moreno S; Hernández B; Dronda F
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():9-13. PubMed ID: 20116611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.
    Flandre P
    Ann Intern Med; 2011 Sep; 155(6):402-3; author reply 403. PubMed ID: 21930863
    [No Abstract]   [Full Text] [Related]  

  • 57. Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.
    Kuchenbecker RS; Reis MM; Barreiro G
    Ann Intern Med; 2011 Sep; 155(6):402; author reply 403. PubMed ID: 21930862
    [No Abstract]   [Full Text] [Related]  

  • 58. HIV protease inhibitors: recent clinical trials and recommendations on use.
    Fernández-Montero JV; Barreiro P; Soriano V
    Expert Opin Pharmacother; 2009 Jul; 10(10):1615-29. PubMed ID: 19527188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetic interaction between rifampicin and ritonavir-boosted atazanavir in HIV-infected patients.
    Mallolas J; Sarasa M; Nomdedeu M; Soriano A; López-Púa Y; Blanco JL; Martínez E; Gatell JM
    HIV Med; 2007 Mar; 8(2):131-4. PubMed ID: 17352770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction.
    Friedland G; Andrews L; Schreibman T; Agarwala S; Daley L; Child M; Shi J; Wang Y; O'Mara E
    AIDS; 2005 Oct; 19(15):1635-41. PubMed ID: 16184033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.